Literature DB >> 9360970

Incorporation of norvaline at leucine positions in recombinant human hemoglobin expressed in Escherichia coli.

I Apostol1, J Levine, J Lippincott, J Leach, E Hess, C B Glascock, M J Weickert, R Blackmore.   

Abstract

We report here a novel finding that norvaline can be incorporated in place of leucine in recombinant human hemoglobin expressed in Escherichia coli. The presence of the norvaline was confirmed by several analytical methods such as amino acid analysis, peptide mapping, electrospray mass spectrometry, and Edman protein sequencing. It appears that substitution is distributed across both the beta- and di-alpha-globins in purified recombinant hemoglobin. The level of misincorporation correlated with the ratio of the free norvaline/leucine pool available in the cell culture. This suggests that the incorporation of norvaline for leucine occurs through misaminoacylation of tRNALeu, similar to the misincorporation of norleucine for methionine found in many recombinant proteins expressed in E. coli.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9360970     DOI: 10.1074/jbc.272.46.28980

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  28 in total

1.  Application of high-precision isotope ratio monitoring mass spectrometry to identify the biosynthetic origins of proteins.

Authors:  I Apostol; P D Brooks; A J Mathews
Journal:  Protein Sci       Date:  2001-07       Impact factor: 6.725

2.  Kinetic partitioning between synthetic and editing pathways in class I aminoacyl-tRNA synthetases occurs at both pre-transfer and post-transfer hydrolytic steps.

Authors:  Nevena Cvetesic; John J Perona; Ita Gruic-Sovulj
Journal:  J Biol Chem       Date:  2012-05-30       Impact factor: 5.157

3.  Detecting low level sequence variants in recombinant monoclonal antibodies.

Authors:  Yi Yang; Alex Strahan; Charlene Li; Amy Shen; Hongbin Liu; Jun Ouyang; Viswanatham Katta; Kathleen Francissen; Boyan Zhang
Journal:  MAbs       Date:  2010-05-06       Impact factor: 5.857

4.  Mutational unmasking of a tRNA-dependent pathway for preventing genetic code ambiguity.

Authors:  Amy M Williams; Susan A Martinis
Journal:  Proc Natl Acad Sci U S A       Date:  2006-02-27       Impact factor: 11.205

5.  Amino acid toxicities of Escherichia coli that are prevented by leucyl-tRNA synthetase amino acid editing.

Authors:  Vrajesh A Karkhanis; Anjali P Mascarenhas; Susan A Martinis
Journal:  J Bacteriol       Date:  2007-09-21       Impact factor: 3.490

6.  Investigation into the misincorporation of norleucine into a recombinant protein vaccine candidate.

Authors:  Joyce Ni; Meg Gao; Andrew James; Jiansheng Yao; Tao Yuan; Bruce Carpick; Tony D'Amore; Patrick Farrell
Journal:  J Ind Microbiol Biotechnol       Date:  2015-04-05       Impact factor: 3.346

7.  Glycine to glutamic acid misincorporation observed in a recombinant protein expressed by Escherichia coli cells.

Authors:  Yunping Huang; Brian O'Mara; Matthew Conover; Richard Ludwig; Jinmei Fu; Li Tao; Zheng Jian Li; Siegfried Rieble; Michael J Grace; Reb J Russell
Journal:  Protein Sci       Date:  2012-03-16       Impact factor: 6.725

8.  Discovery and investigation of misincorporation of serine at asparagine positions in recombinant proteins expressed in Chinese hamster ovary cells.

Authors:  Dingyi Wen; Malgorzata M Vecchi; Sheng Gu; Lihe Su; Jana Dolnikova; Yao-Ming Huang; Susan F Foley; Ellen Garber; Nels Pederson; Werner Meier
Journal:  J Biol Chem       Date:  2009-09-25       Impact factor: 5.157

9.  Top-Down Mass Spectrometry Analysis of Membrane-Bound Light-Harvesting Complex 2 from Rhodobacter sphaeroides.

Authors:  Yue Lu; Hao Zhang; Weidong Cui; Rafael Saer; Haijun Liu; Michael L Gross; Robert E Blankenship
Journal:  Biochemistry       Date:  2015-12-02       Impact factor: 3.162

10.  Preparation of ultrapure bovine and human hemoglobin by anion exchange chromatography.

Authors:  Guoyong Sun; Andre F Palmer
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2008-02-26       Impact factor: 3.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.